"Clear" txhais li cas?
Tus tsiaj tsis nqa qhov kev hloov pauv. Nws yuav tsis tsim tus kab mob thiab yuav tsis hla nws mus.
The DNA test for Achromatopsia Type 3 (PRAcd) in German Shorthaired Pointers is essential for responsible breeding. This genetic screening identifies carriers of the PRAcd mutation, which causes progressive vision loss and color blindness in affected dogs. Early detection through DNA testing helps breeders prevent passing this hereditary condition to future generations. By using the PRAcd test, owners can ensure healthier litters and maintain the breed’s overall well-being. Regular testing supports informed breeding decisions and promotes the longevity of German Shorthaired Pointers. Protect your dog’s vision and contribute to breed health with the Achromatopsia Type 3 DNA test.
The DNA test for Achromatopsia Type 3 (PRAcd) in German Shorthaired Pointers helps identify carriers and affected dogs. This inherited condition causes complete color blindness and vision problems. Early testing allows breeders to make informed decisions to reduce the risk of passing the disorder. By screening breeding dogs, the prevalence of PRAcd can be minimized in future generations. Responsible breeding ensures healthier dogs with better quality of life.
Qhov kev kuaj DNA no suav nrog pib los ntawm peb pob Basic — thiab tseem yog ib feem ntawm cov pob khoom Basic, Standard, Advanced, Complete.
Saib DNA Test Packs →Achromatopsia Type 3, also known as Progressive Retinal Atrophy with complete color blindness (PRAcd), is a hereditary condition that affects the vision of German Shorthaired Pointers. This genetic disorder results from mutations in specific genes that are crucial for the proper functioning of photoreceptor cells in the retina, leading to vision impairment over time.
Dogs affected by Achromatopsia Type 3 typically exhibit symptoms such as a lack of color vision, difficulty seeing in bright light, and potential night blindness. Owners may notice that their dogs have trouble navigating their environment, particularly in brightly lit areas, as their ability to perceive colors is significantly diminished.
This condition is inherited in an autosomal recessive manner, meaning that both copies of the gene must be mutated for the dog to express the disease. Carriers, which have one normal and one mutated gene, do not show symptoms but can pass the condition to their offspring. Identifying carriers through DNA testing is essential for responsible breeding practices, as it helps prevent the propagation of the condition in future generations.
While Achromatopsia Type 3 can lead to significant visual impairment, many dogs adapt well to their condition. Owners can assist by providing a safe environment and ensuring that their pets are comfortable in low-light conditions or areas with bright lighting. Understanding the limitations of their dog's vision allows owners to make necessary adjustments to enhance their pet's quality of life.
Managing a dog with Achromatopsia Type 3 primarily involves environmental modifications rather than medical interventions. Owners should ensure that their living space is free from obstacles that could pose a danger, as affected dogs may not respond to visual cues in the same way as their sighted counterparts. Regular veterinary check-ups are also advised to monitor the dog's overall eye health and address any other potential issues that may arise.
Achromatopsia Type 3 in German Shorthaired Pointers is a serious genetic condition that affects visual perception. Understanding the symptoms, genetic basis, and management strategies is crucial for owners and breeders alike. Through responsible breeding and proper care, the impact of this condition on affected dogs can be alleviated, allowing them to lead fulfilling lives despite their visual challenges.
Tus tsiaj tsis nqa qhov kev hloov pauv. Nws yuav tsis tsim tus kab mob thiab yuav tsis hla nws mus.
Tsis yog. Tus tsiaj no feem ntau noj qab nyob zoo tab sis muaj peev xwm kis tau tus kab mob mus rau nws xeeb.
Nws nqa ob daim ntawv hloov pauv. Cov tsos mob tshwm sim yuav tsum nyob ntawm tus kab mob. Nws yuav tsum tsis txhob bred.
Qee cov kab mob muaj kev sib deev sib deev, yog li lawv cov lus qhia txawv nyob ntawm qhov tsiaj sib deev.
This DNA test detects the mutation associated with Achromatopsia Type 3 In German Shorthaired Pointer (PRAcd) in order to identify clear, carrier, or at-risk animals.
Kev kuaj DNA pab cov neeg yug tsiaj npaj kom muaj kev sib raug zoo dua thiab txo qhov kev pheej hmoo ntawm kev hloov pauv mus rau cov xeeb ntxwv.
Hom qub txeeg qub teg tau tshaj tawm rau qhov kev sim no yog Autosomal Recessive.
This test analyses the mutation CNGB3 c.784G>A.
Tsis tas li. Kev txhais lus nyob ntawm tus qauv qub txeeg qub teg thiab qhov tshwm sim genotype.
Sidjanin Duska J, Lowe Jennifer K, McElwee John L, Milne Bruce S, Phippen Taryn M, Sargan David R, Aguirre Gustavo D, Acland Gregory M, Ostrander Elaine A. Canine CNGB3 mutations establish cone degeneration as orthologous to the human achromatopsia locus ACHM3. Hum Mol Genet. 2002 Aug 1;11(16):1823-33. doi: 10.1093/hmg/11.16.1823.
Koj tus kheej, koj xaiv
Peb siv cov ncuav qab zib tseem ceeb los khiav lub vev xaib. Cov ncuav qab zib xaiv tau (xws li cov chaw muab cov ntsiab lus embedded) raug kaw los ntawm lub neej ntawd thiab tsuas yog qhib yog tias koj pom zoo. Koj tuaj yeem hloov koj qhov kev xaiv txhua lub sijhawm siv lub pob "Cookies".
Yuav tsum tau rau cov yam ntxwv tseem ceeb thiab kev ruaj ntseg. Ib txwm qhib.
Txhim kho cov yam ntxwv zoo li nyiam txuag lossis tsis tshaj tawm embeds.
Pab peb nkag siab txog kev siv qhov chaw. Disabled los ntawm lub neej ntawd.
Kev tshaj tawm / taug qab thoob plaws qhov chaw (qee video / maps embeds). Disabled los ntawm lub neej ntawd.